Comparison of Satisfaction Rates and Erectile Function in Patients Treated with Sildenafil, Intracavernous Prostaglandin E1 and Penile Implant Surgery for Erectile Dysfunction in Urology Practice

Feldman, 1994, Impotence and its medical and psychological correlates: results of the Massachusetts Male Aging Study, J Urol, 151, 54, 10.1016/S0022-5347(17)34871-1

Johannes, 2000, Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts Male Aging Study, J Urol, 163, 460, 10.1016/S0022-5347(05)67900-1

Shabsigh, 2001, Socioeconomic considerations in erectile dysfunction treatment, Urol Clin North Am, 28, 417, 10.1016/S0094-0143(05)70149-X

Goldstein, 1998, Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group, N Engl J Med, 338, 1397, 10.1056/NEJM199805143382001

Montorsi, 1999, Efficacy and safety of fixed-dose oral sildenafil in the treatment of erectile dysfunction of various etiologies, Urology, 53, 1011, 10.1016/S0090-4295(98)00643-8

McMahan, 2000, Efficacy, safety and patient acceptance of sildenafil citrate as treatment for erectile dysfunction, J Urol, 164, 1192, 10.1016/S0022-5347(05)67139-X

Hatzichristou, 2002, Sildenafil citrate: lessons learned from 3 years of clinical experience, Int J Impot Res, 14, S43, 10.1038/sj.ijir.3900805

Porst, 1996, The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience, J Urol, 155, 802, 10.1016/S0022-5347(01)66315-8

Linet, 1996, Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group, N Engl J Med, 334, 873, 10.1056/NEJM199604043341401

Willke, 1997, Quality of life effects of alprostadil therapy for erectile dysfunction, J Urol, 157, 2124, 10.1016/S0022-5347(01)64692-5

Gupta, 1997, Predictors of success and risk factors for attrition in the use of intracavernous injection, J Urol, 157, 1681, 10.1016/S0022-5347(01)64834-1

Irwin, 1994, High attrition rate with intracavernous prostaglandin E1 for impotency, Urology, 43, 84, 10.1016/S0090-4295(94)80272-6

Carson, 2000, Efficacy, safety and patient satisfaction outcomes of the AMS 700 CX inflatable penile prosthesis: results of a long-term multicenter study, J Urol, 164, 376, 10.1016/S0022-5347(05)67364-8

Wilson, 1999, Comparison of mechanical reliability of original and enhanced Mentor Alpha 1 penile prosthesis, J Urol, 162, 715, 10.1097/00005392-199909010-00022

Sexton, 1998, Comparison of long-term outcomes of penile prostheses and intracavernosal injection therapy, J Urol, 159, 811, 10.1016/S0022-5347(01)63739-X

Altof, 1999, EDITS: development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction, Urology, 53, 793, 10.1016/S0090-4295(98)00582-2

Rosen, 1997, The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction, Urology, 49, 822, 10.1016/S0090-4295(97)00238-0

McLaren, 1992, Patient and partner satisfaction with the AMS 700 penile prosthesis, J Urol, 147, 62, 10.1016/S0022-5347(17)37134-3

Whalen, 1991, Patient satisfaction with Mentor inflatable penile prosthesis, Urology, 37, 531, 10.1016/0090-4295(91)80318-2

Giuliano, 2000, Switching from intracavernous prostaglandin E1 injections to oral sildenafil citrate in patients with erectile dysfunction: results of a multicenter European study, J Urol, 164, 708, 10.1016/S0022-5347(05)67286-2

Hatzichristou, 1998, Current treatment and future perspectives for erectile dysfunction, Int J Impot Res, suppl, 10, S3

Hatzichristou, 2000, Sildenafil versus intracavernous injection therapy: efficacy and preference in patients on intracavernous injection for more than 1 year, J Urol, 164, 1197, 10.1016/S0022-5347(05)67140-6

Jarow, 1999, Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment, J Urol, 162, 722, 10.1097/00005392-199909010-00024